| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/10/2004 | WO2004048256A2 Separation of carbon nanotubes dispersed by nucleic acids |
| 06/10/2004 | WO2004048255A2 Dispersion of carbon nanotubes by nucleic acids |
| 06/10/2004 | WO2004047767A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047764A2 Modulation of hiv replication by rna interference |
| 06/10/2004 | WO2004047758A2 Methods of therapy and diagnosis using targeting of cells that express p2y10 |
| 06/10/2004 | WO2004047742A2 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 06/10/2004 | WO2004047741A2 Modulation of iap-like expression |
| 06/10/2004 | WO2004047740A2 Composition and method for treating lupus nephritis |
| 06/10/2004 | WO2004047736A2 Modulation of bcl2-associated athanogene expression |
| 06/10/2004 | WO2004047623A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047514A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004037202A9 Gb virus c and methods of treating viral infections |
| 06/10/2004 | WO2004031362A8 Multimeric protein engineering |
| 06/10/2004 | WO2004029278A3 Aav itr-mediated modulation |
| 06/10/2004 | WO2004000995A3 Methods, probes, and accessory molecules for detecting single nucleotide polymorphisms |
| 06/10/2004 | WO2003106476A8 Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity |
| 06/10/2004 | WO2003103480A9 Gene cluster analysis for coronary artery disease |
| 06/10/2004 | WO2003089902A3 Displacement assay for detection of small molecules |
| 06/10/2004 | WO2003087323A3 Biologic modulations with nanoparticles |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | WO2003039346A9 Diagnostics and therapeutics for ocular abnormalities |
| 06/10/2004 | US20040111768 Transcription factor stress-related proteins and methods of use in plants |
| 06/10/2004 | US20040110930 Artificial polypeptide comprising immunoglobulin fragments generated in plant; tissue engineering |
| 06/10/2004 | US20040110730 Using salts of hydrazine and/or (thio)carbonylamino derivatives of hydrazine for conjugation and immobilization of biomolecules; diagnosis |
| 06/10/2004 | US20040110710 Methods of reducing ischemic injury |
| 06/10/2004 | US20040110703 Gene expression inhibition; molecular hybridization; drug screening, medical diagnosis |
| 06/10/2004 | US20040110698 Oligonucleotides and methods using same for treating cox-ll associated diseases |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110308 quenchers can be conjugated to a variety of biologically relevant compounds, including antigens, steroids, vitamins, drugs, haptens, metabolites, toxins, environmental pollutants, amino acids, peptides, proteins, nucleotides, oligonucleotides etc |
| 06/10/2004 | US20040110295 Plasmid that codes heterologous nucleotide sequences and is capable of expressing recombinant polypeptides eukaryotic cells; gene transfer tools |
| 06/10/2004 | US20040110253 used in studying T cells and their antigenic targets in autoimmunity, hypersensitivity, and cancer; for drug screening; genetic engineering |
| 06/10/2004 | US20040110235 for the treatment of diabetes and other diseases using systematic evolution of ligands by exponential enrichment (SELEX) |
| 06/10/2004 | US20040110232 Novel cark protein and nucleic acid molecules and uses therefor |
| 06/10/2004 | US20040110224 Segment synthesis |
| 06/10/2004 | US20040110220 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 06/10/2004 | US20040110210 Bacillus stearothermophilus SSB protein and use thereof |
| 06/10/2004 | US20040110200 Polymorphism detection among homologous sequences |
| 06/10/2004 | US20040110190 Isolated nucleic acid comprising a polynucleotide encoding a polypeptide which has expansin activity; altering properties which may effect growth, flexibility, and mechanical strength in tissues in which they are expressed; use in paper industry |
| 06/10/2004 | US20040110183 Methods for the survey and genetic analysis of populations |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110168 Diagnostics and therapeutics for osteoporosis |
| 06/10/2004 | US20040110161 Identifying genetic aberrations in nucleic acid sequences using base mispairing-binding proteins; genomics |
| 06/10/2004 | US20040110155 Modulation of SLC26A2 expression |
| 06/10/2004 | US20040110152 Antisense oligonucleotides for controlling expression of zinc-dependent endopeptidase and for treatment of hyperproliferative disorders |
| 06/10/2004 | US20040110132 Method for concentrate nucleic acids |
| 06/10/2004 | CA2796924A1 Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 06/10/2004 | CA2507165A1 Optical information carrier comprising immobilized proteorhodopsin |
| 06/10/2004 | CA2507125A1 Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 06/10/2004 | CA2506666A1 Nact as a target for lifespan expansion and weight reduction |
| 06/10/2004 | CA2505784A1 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | CA2505266A1 2'-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
| 06/10/2004 | CA2504633A1 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 06/10/2004 | CA2504561A1 Composition and method for treating lupus nephritis |
| 06/10/2004 | CA2485950A1 Methods for cohort selection and longevity studies |
| 06/09/2004 | EP1425414A2 Genetic markers for improved disease resistance in animals (nramp1) |
| 06/09/2004 | EP1036094A4 Cyp7 promoter-binding factors |
| 06/09/2004 | EP0920539A4 Methods for detection of nucleic acid sequences in urine |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0386229B2 Support-bound oligonucleotides |
| 06/09/2004 | CN1502625A Oligopeptide suppressor of matrix metalloprotease 2 |
| 06/09/2004 | CN1502622A Diuridine tetraphosphate or salt crystal thereof, process for producing the same, and process for producing the compounds |
| 06/08/2004 | US6747143 Methods for polymer synthesis |
| 06/08/2004 | US6747142 Multiple methoxyoxalamido and succinimido precursors for nucleophilic addition |
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/03/2004 | WO2004046691A2 Uncaging devices |
| 06/03/2004 | WO2004046688A2 Cftr allele detection assays |
| 06/03/2004 | WO2004046365A2 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | WO2004046344A2 Polynucleotide sequence detection assays |
| 06/03/2004 | WO2004046339A2 Caged sensors, regulators and compounds and uses thereof |
| 06/03/2004 | WO2004046313A2 Methods and compositions for determining methylation profiles |
| 06/03/2004 | WO2004046168A2 Recombinant hiv-1 subclass d envelope glycoproteins |
| 06/03/2004 | WO2004046161A1 Novel 2’,5’-oligoadenylic acid analogues |
| 06/03/2004 | WO2004046160A2 Amino-lna, thio-lna and alpha-l-oxy-ln |
| 06/03/2004 | WO2004046147A1 Polynucleotide derivative and use thereof |
| 06/03/2004 | WO2004046069A2 Adrenergic receptors |
| 06/03/2004 | WO2004045558A2 Compositions and methods for treating thrombotic disorders |
| 06/03/2004 | WO2004045547A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 06/03/2004 | WO2004045545A2 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 06/03/2004 | WO2004045543A2 Functional and hyperfunctional sirna |
| 06/03/2004 | WO2004045529A2 West nile virus vaccine |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004045371A2 Methods for diagnosing the presence or stage of cancer |
| 06/03/2004 | WO2004045364A2 Methods of detecting ovarian neoplasia |
| 06/03/2004 | WO2004026109A9 Molecular targets of cancer and aging |
| 06/03/2004 | WO2004022708A3 Genes and proteins altering tau-related neurodegeneration |
| 06/03/2004 | WO2004020451A9 Group b streptococcal phage lysin |
| 06/03/2004 | WO2004002294B1 Plasma or serum marker and process for detection of cancer |
| 06/03/2004 | WO2004001379A3 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 06/03/2004 | WO2004001015A3 Method for sequencing nucleic acids |
| 06/03/2004 | WO2003099228A3 Compositions and processes for inhibiting gene expression using polynucleotides |
| 06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2002097108A3 Antisense modulation of dual specific phosphatase 5 expression |
| 06/03/2004 | US20040106784 Comprises nucleotide sequences coding negative regulators of cytokine signal transduction for use in screening modulators for treatment of diabetes, inflammation, metabolic and cancer disorders |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106773 Human tuberoinfundibular peptide of 39 residues |
| 06/03/2004 | US20040106570 down-regulate the expression of the RI alpha gene while producing fewer side effects than conventional oligonucleotides. In particular demonstrate reduced mitogenicity, reduced activation of complement and reduced antithrombotic properties |